COL1A2 and osteogenesis imperfecta: Approximately ~85–90% of OI patients harbor heterozygous mutations in genes encoding type I collagen COL1A1 [MIM: 120150] or COL1A2 [MIM: 120160], which are the genes that encode the α1(I) and α2(I) chain of type I collagen, respectively.